4 not yet recruiting, 3 recruiting, 2 completed, 2 unknown. 12 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 12 | Not yet recruiting 4, Recruiting 3, Completed 2, Unknown 2, Suspended 1 |
Follow Systemic Sclerosis: new trials by email Literature Review of Systemic Sclerosis trials Research Report on Systemic Sclerosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hyaluronidase for Sclerodactyly in Systemic Sclerosis Trial Hyaluronidase (Hylenex) - Systemic Sclerosis, Sclerodactyly | Early Phase 1 | Not yet recruiting | Medical University of South Carolina | 10 | 2026-11-01 | 2026-10-16 |
| CD19/BCMA-Targeted Universal CAR-T Cell Injection for the Treatment of Autoimmune Diseases RD06-05 CAR-T Cell Injection - SLE - Systemic Lupus Erythematosus, Systemic Sclerosis | Early Phase 1 | Not yet recruiting | Nanjing Bioheng Biotech Co., Ltd. | 30 | 2026-09-01 | 2026-07-16 |
| Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases anti-CD19/BCMA U CAR T cells - Autoimmune Diseases, Systemic Lupus Erythematosus | Early Phase 1 | Recruiting | Changhai Hospital | 60 | 2026-02-20 | 2026-02-25 |
| Early Clinical Study of UTAA91 Injection for the Treatment of Relapsed/Refractory Autoimmune Diseases UTAA91 injection - Systemic Lupus Erythematosus, Rheumatoid Arthritis | Early Phase 1 | Not yet recruiting | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 15 | 2025-05-18 | 2025-05-14 |
| Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases RD06-05 CART Cell Injection - SLE, Systemic Sclerosis | Early Phase 1 | Recruiting | Nanjing Bioheng Biotech Co., Ltd. | 18 | 2025-01-03 | 2026-02-02 |
| Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases CD19 or CD19-BCMA CAR-T - SLE (Systemic Lupus), Systemic Sclerosis | Early Phase 1 | Recruiting | Nanjing Bioheng Biotech Co., Ltd. | 20 | 2024-09-14 | 2026-03-06 |
| Clinical Study on Targeted CD19CAR-T Therapy for Autoimmune Diseases RD06-04 CART Cell Injection - Systemic Lupus Erythematosus, Systemic Sclerosis | Early Phase 1 | Suspended | Nanjing Bioheng Biotech Co., Ltd. | 12 | 2024-09-13 | 2026-02-03 |
| The Safety and Efficacy of Anti-CD19 CAR-T Cells in Patients With Relapsed/Refractory Autoimmune Diseases anti-CD19-CAR-T cells - Systemic Lupus Erythematosus (SLE), Sjogren's Syndrome | Early Phase 1 | Not yet recruiting | First Affiliated Hospital of Wenzhou Medical University | 9 | 2024-05-27 | 2024-05-17 |
| Preliminary Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases T cell injection targeting CD19 chimeric antigen receptor - Systemic Lupus Erythematosus, Idiopathic Inflammatory Myopathies | Early Phase 1 | Unknown | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 10 | 2024-05-14 | 2024-05-16 |
| Injection of Autologous Adipose-derived Stromal Vascular Fraction in the Finger of Systemic Sclerosis Patients SVF injection - Systemic Sclerosis | Early Phase 1 | Completed | Suk-Ho Moon | 20 | 2018-07-01 | 2020-10-08 |
| The Effect of High Dose Methylprednisolone on Nailfold in Early Systemic Sclerosis ( SSc ) Methylprednisolone, sodium chloride - Systemic Sclerosis, Raynaud Phenomena | Early Phase 1 | Unknown | Radboud University Medical Center | 30 | 2017-01-01 | 2019-11-29 |
| Long Term Effect of Buspirone on Esophageal Function and Esophageal Symptoms in Patients With Systematic Sclerosis (SSc) buspirone - Systemic Sclerosis | Early Phase 1 | Completed | Laikο General Hospital, Athens | 22 | 2014-12-01 | 2016-10-24 |
Scleroderma, Systemic (12) · Lupus Erythematosus, Systemic (7) · Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (6) · Myositis (6) · Autoimmune Diseases (5) · Sjogren's Syndrome (5) · Arthritis, Rheumatoid (3) · Antiphospholipid Syndrome (1) · Liver Cirrhosis, Biliary (1) · Purpura, Thrombocytopenic, Idiopathic (1)
Connective Tissue Diseases (12) · Skin Diseases (12) · Skin and Connective Tissue Diseases (12) · Immune System Diseases (9) · Arthritis (7) · Joint Diseases (7) · Musculoskeletal Diseases (7) · Rheumatic Diseases (7) · Cardiovascular Diseases (6) · Muscular Diseases (6) · Nervous System Diseases (6) · Neuromuscular Diseases (6) · Skin Diseases, Vascular (6) · Systemic Vasculitis (6) · Vascular Diseases (6)
Antigens, CD19 (1) · Buspirone (1) · Hyaluronoglucosaminidase (1) · Methylprednisolone (1) · Methylprednisolone Hemisuccinate (1) · Sodium Chloride (1)
Nanjing Bioheng Biotech Co., Ltd. (4) · PersonGen BioTherapeutics (Suzhou) Co., Ltd. (2) · Changhai Hospital (1) · First Affiliated Hospital of Wenzhou Medical University (1) · Laikο General Hospital, Athens (1) · Medical University of South Carolina (1) · Radboud University Medical Center (1) · Suk-Ho Moon (1)
China (7) · Greece (1) · Netherlands (1) · South Korea (1) · United States (1)
Georgios Karamanolis (1) · Jian Wu, Doctor (1) · LI Sun, Master's (1) · Madelon Vonk, Dr. (1) · Qiong Fu, Doctor (1) · Seung-Ki Kwok (1) · Suk-Ho Moon, MD, PhD (1)